The Genomic Medicine Alliance proudly announces the publication of the Special Issue with the theme "Public Health Pharmacogenomics", guest edited by Professor George P. Patrinos (University of Patras, Greece) and published by Public Health Genomics, the official journal of the Genomic Medicine Alliance.
Pharmacogenomics has a pivotal role in genomic medicine aiming to delineate drug efficacy and toxicity with the underlying genomic composition in genes involved in the pharmacokinetics and pharmacodynamics of drug regimens. Although there have been major leaps in pharmacogenomic research, facilitated by the genomic technology revolution, the pace of these discoveries have not met with reciprocal advances in the translation of these findings into the clinic, resulting into the personalization of conventional therapeutic interventions. To this end, there are often significant barriers that hamper the smooth incorporation of pharmacogenomics research findings in the daily medical practice, which have to do more with disciplines related to Public Health Genomics rather than pharmacogenomics research itself.
This Special issue is a collection of timely contributions of perspectives and original articles that touch upon pharmacogenomics in relation to Public Health Genomics disciplines, namely ethics in genomics, economic evaluation in genomic medicine, genome informatics and knowledgebases, and the involvement and genetics education of the various stakeholders in the field of pharmacogenomics.
To access the full content of the Special Issue "Public Health Pharmacogenomics", please click here.